134 related articles for article (PubMed ID: 9356783)
1. The effect of long-term treatment with hypotensive drugs on blood viscosity and erythrocyte deformability in patients with essential arterial hypertension.
Martínez M; Vayá A; Labios M; Gabriel F; Guiral V; Aznar J
Clin Hemorheol Microcirc; 1997; 17(3):193-8. PubMed ID: 9356783
[TBL] [Abstract][Full Text] [Related]
2. [The effect of aspirin on rheological properties of erythrocytes in essential hypertension].
Korbut RA; Adamek-Guzik T
Przegl Lek; 2002; 59(2):71-5. PubMed ID: 12152252
[TBL] [Abstract][Full Text] [Related]
3. Effects of Ramipril and Isradipin on hemorheological profiles in patients with arterial hypertension.
Muravyov AV; Zaitsev LG; Muravyov AA; Yakusevich VV; Sirotkina AM
Clin Hemorheol Microcirc; 1998 Jul; 18(2-3):185-90. PubMed ID: 9699040
[TBL] [Abstract][Full Text] [Related]
4. Hemorheological and hemodynamic parameters in patients with essential hypertension and their modification by alpha-1 inhibitor drug treatment.
Toth K; Kesmarky G; Vekasi J; Nemes J; Czopf L; Kapronczay P; Halmosi R; Papp E; Juricskay I
Clin Hemorheol Microcirc; 1999; 21(3-4):209-16. PubMed ID: 10711745
[TBL] [Abstract][Full Text] [Related]
5. [Influence of risk factors and pharmacological treatment on mortality in patients with essential hypertension].
Román O; Cuevas G; Bunout D
Rev Med Chil; 1998 Jul; 126(7):745-52. PubMed ID: 9830766
[TBL] [Abstract][Full Text] [Related]
6. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
8. [Changes in blood rheological properties in patients with hypertension].
Shabanov VA; Terekhina EV; Kostrov VA
Ter Arkh; 2001; 73(10):70-3. PubMed ID: 11763523
[TBL] [Abstract][Full Text] [Related]
9. Effects of antihypertensive therapy on hemorheological profiles in female hypertensive patients with initially low or high whole blood viscosity.
Muravyov AV; Meiselman HJ; Yakusevich VV; Zamishlayev AV
Clin Hemorheol Microcirc; 2002; 26(2):125-35. PubMed ID: 12082261
[TBL] [Abstract][Full Text] [Related]
10. Lack of effects of calcium antagonists on red blood cell deformability in hypertension.
Lin MS; Huang CS; Leen DY
Int J Clin Pharmacol Ther Toxicol; 1988 Dec; 26(12):585-7. PubMed ID: 3209275
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive persistence and drug class.
Marentette MA; Gerth WC; Billings DK; Zarnke KB
Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422
[TBL] [Abstract][Full Text] [Related]
12. [Beneficial effects of statins and angiotensin converting enzyme inhibitors on aggregability of red blood cells in hypertensive patients].
Korbut RA; Guzik B; Adamek-Guzik T; Korbut R
Folia Med Cracov; 2006; 47(1-4):37-49. PubMed ID: 18038611
[TBL] [Abstract][Full Text] [Related]
13. Haemorheological disturbances in hypertensive type 2 diabetic patients--influence of antihypertensive therapy.
Kearney-Schwartz A; Virion JM; Stoltz JF; Drouin P; Zannad F
Fundam Clin Pharmacol; 2007 Aug; 21(4):387-96. PubMed ID: 17635177
[TBL] [Abstract][Full Text] [Related]
14. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
[TBL] [Abstract][Full Text] [Related]
15. Current status of antihypertensive prescription and associated blood pressure control in Japan.
Mori H; Ukai H; Yamamoto H; Saitou S; Hirao K; Yamauchi M; Umemura S
Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149
[TBL] [Abstract][Full Text] [Related]
16. [Lisinopril effects on cerebral blood flow and blood rheology in hypertensive patients].
Markova LI; Kuznetsova IV; Radzevich AE
Ter Arkh; 2004; 76(11):41-3. PubMed ID: 15658536
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
[TBL] [Abstract][Full Text] [Related]
18. Long-term safety of antihypertensive therapy.
Grossman E; Messerli FH
Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
[TBL] [Abstract][Full Text] [Related]
19. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
[TBL] [Abstract][Full Text] [Related]
20. [Study on the compliance of antihypertensive drugs in patients with hypertension].
Guo H; He H; Jiang J
Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Dec; 22(6):418-20. PubMed ID: 11851054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
